Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Current Leases (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Current Leases for 5 consecutive years, with $11000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases changed N/A to $11000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $11000.0 for FY2025, N/A changed from the prior year.
  • Current Leases for Q4 2025 was $11000.0 at Actinium Pharmaceuticals, down from $599000.0 in the prior quarter.
  • The five-year high for Current Leases was $599000.0 in Q3 2025, with the low at $11000.0 in Q4 2023.
  • Average Current Leases over 5 years is $295368.4, with a median of $349000.0 recorded in 2021.
  • Peak annual rise in Current Leases hit 5345.45% in 2025, while the deepest fall reached 97.96% in 2025.
  • Over 5 years, Current Leases stood at $62000.0 in 2021, then soared by 696.77% to $494000.0 in 2022, then crashed by 97.77% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then changed by 0.0% to $11000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $11000.0, $599000.0, and $11000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.